Use of dietary supplements containing polyvalent cations and antacids among people with HIV and its impact on viral suppression-Reference-Cited by-同舟云学术

Use of dietary supplements containing polyvalent cations and antacids among people with HIV and its impact on viral suppression

Published:2021-06-01 Issue:12 Volume:35 Page:2054-2057
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Peng An-Ting,Huang Sung-Hsi,Sun Hsin-Yun,Huang Yi-Chia,Chuang Yu-Chung,Wu Pei-Ying,Chen Ling-Ya,Chang Hsi-Yen,Luo Yu-Zhen,Liu Wen-Chun,Kuo Han-Yueh,Hung Chien-Ching

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference10 articles.

1. Effect of antacids on the pharmacokinetics of raltegravir in human immunodeficiency virus-seronegative volunteers;Kiser;Antimicrob Agents Chemother,2010

2. Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers;Patel;J Antimicrob Chemother,2011

3. Pharmacokinetics of once-daily boosted elvitegravir when administered in combination with acid-reducing agents;Ramanathan;J Acquir Immune Defic Syndr,2013

4. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir;Krishna;J Pharm Pharmacol,2016

5. Pharmacokinetics of dolutegravir when administered with mineral supplements in healthy adult subjects;Song;J Clin Pharmacol,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of the Drug–Drug Interactions Between Valproic Acid and Dolutegravir—A Case Study;Therapeutic Drug Monitoring;2024-05-14

2. Polypharmacy and potential drug–drug interactions among people living with HIV in the era of integrase strand-transferase inhibitor-based antiretroviral therapy;International Journal of Antimicrobial Agents;2024-02

3. Comparing Safety and Effectiveness of Antiretroviral Therapy in a Diverse Population of Older People With HIV;The Senior Care Pharmacist;2023-11-01

4. Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy;Journal of Global Antimicrobial Resistance;2022-06